M&A Pickup Pushes This ETF Higher
February 21, 2014 at 07:00 AM EST
Although there was no “Merger Monday” because U.S. markets were closed for a public holiday, this will go down as a big week on the mergers and acquisitions front. On Tuesday, generic drugmaker Actavis (NYSE: ACT) announced it will acquire rival Forest Laboratories (NYSE: FRX) for $25 billion....
